comprehensive -WSS

comprehensive

author：leisure time 2025-10-01 05:39:23 - browse：24443

Stock photo of a surgeon holding a digital tablet in a medical setting – health tech coverage from STAT — Adobe

A new $50 million nonprofit initiative aims to independently evaluate health technologies’ impact on costs and quality, an attempt to help patients, payers, and providers sort over-hyped products from ones that actually move the needle.

The Peterson Center on Healthcare, a nonprofit supporting programs that raise care quality and drive down costs, announced the new Peterson Health Technology Institute Tuesday. The institute plans to publish its methodology for assessing new health technology as soon as September, and start publishing reports on specific sectors, like disease types or tech mechanisms, in 2024, executive director Caroline Pearson told STAT.

Especially after digital health investment surged early in the pandemic, health apps and software have proliferated — both those marketed to consumers and designed for organizations like health systems or insurers. Venture funding has since contracted, but customers are still faced with “an overwhelming number of solutions,” Pearson said. “It’s hard to know what is high value in this space.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： The lessons of Aduhelm, an Alzheimer's drug that was not to be

focus

WSS

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

VC firm RA Capital starts a new synthetic biology incubator

Novo Nordisk to expand supply of Wegovy for U.S. patients

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Hospitals, health systems can help patients avoid medical debt

CDC: Cases of alpha

knowledge

comprehensive

focus

Dobbs anniversary: the lost opportunity of abortion as health care

Will biotech layoffs continue through 2023?

DIEP, the 'gold standard' of breast reconstruction, is under threat

The lessons of Aduhelm, an Alzheimer's drug that was not to be

How one medical school became remarkably diverse

FDA drug safety: Singulair case shows systemic surveillance flaws

Jerome Adams on the need for new antivirals for Covid

Congressmen charge Covid hearing ‘could have been an email’

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

ARCH Venture Partners is raising $3 billion for a life sciences fund

entertainment

Commercial surrogacy can be ethical, despite pope’s claims

Biden to sign 'historic' executive order on how US military handles sexual assault cases

Do digital therapeutics have a future in medicine?

Timeline: Special counsel's probe into Trump's handling of classified documents

Biden administration opens offers in Medicare drug price negotiations

Biden jokes that Republicans may impeach him because inflation is starting to cool down

hotspot

focus

hotspot

focus